Industry Primer: Microcapsules, Liposomes, and Cocrystals – What Do These Delivery Technologies Actually Do?

If you've followed the dietary supplement market recently, you've likely encountered claims like: "Liposomal curcumin has dozens of times higher bioavailability than ordinary curcumin," "Cocrystal technology transforms poorly absorbed coenzyme Q10 into a highly absorbable form," or "Microencapsulated vitamin C is several times more stable than standard vitamin C." Microcapsules, liposomes, and cocrystals—three terms once confined to pharmaceutical literature—now appear regularly on brand pages, sales scripts, and product descriptions.

They all sound like "cutting-edge tech." But neither brands nor consumers can usually explain beyond "this technology is impressive"—what specific problem does it solve, and at what cost?

1. Microcapsules: The Most Mature Physical Encapsulation Technology

Microencapsulation is a physical coating process. It uses natural or synthetic polymers as wall materials to enclose active ingredients, forming micro-capsules typically 1–250 μm in diameter [1].

Think of it this way: the active ingredient is the "core," and the wall material is the "shell." The shell doesn't alter the core's chemistry—it isolates it from light, oxygen, moisture, and heat. Proper wall material selection also modifies dispersion behavior in specific media:

• Lipophilic cores coated with hydrophilic shells become dispersible in water;

• Hydrophilic cores coated with lipophilic shells become dispersible in oil.

By engineering the shell's dissolution properties, microcapsules can also enable sustained release or enteric release (e.g., no release in the stomach, release in the intestine).

Advantages: Mature technology, controllable cost, flexible dosage forms, and suitability for large-scale production. Significant protection of active ingredients extends shelf life and masks unpleasant tastes. Common applications include vitamins A, C, D, E, K, B-complex, DHA/EPA, and natural pigments. The primary goal is not "multiplying absorption by tens of times" but "ensuring the ingredient reaches the consumer without losing potency" [1].

2. Liposomes: Biomimetic Nanocarriers

Liposomes are the most structurally sophisticated of the three.

When phospholipids are dispersed in an aqueous phase, they spontaneously assemble into closed vesicles with a bilayer structure—chemically nearly identical to human cell membranes. Hydrophilic "heads" face outward, lipophilic "tails" face inward, forming a hollow sphere. Hydrophilic actives are encapsulated in the inner aqueous compartment; lipophilic actives embed within the lipid bilayer. Particle sizes range from 20 nm to 10 μm.

The brilliance lies in active "camouflage," not passive "wrapping." Because liposomal material mimics cell membranes, cells recognize them as "friendly" and internalize them via membrane fusion or endocytosis—delivering actives efficiently into cells. They can also be absorbed through intestinal lymphatic pathways, reducing first-pass hepatic metabolism.

Liposomes are best suited for ingredients with intrinsically poor oral absorption but high potency once effectively delivered. Curcumin is a classic example—double-layered nano-liposomal curcumin (BNT–C060) showed a 53-fold higher Cmax in humans than free curcumin [2]. Coenzyme Q10, silymarin, NMN, and resveratrol also benefit from liposomal delivery [3]. The phospholipid bilayer can co-load both hydrophilic and lipophilic compounds, enabling multi-nutrient co-delivery.

3. Cocrystals: Molecular-Level Crystal Engineering

Cocrystal technology differs fundamentally—it does not "encapsulate" or act as a "carrier." Instead, active ingredient molecules and a physiologically acceptable coformer (cocrystal former) interact via non-covalent bonds (primarily hydrogen bonds) to self-assemble into a new crystalline structure with a fixed stoichiometric ratio.

Two levels of understanding:

Level 1: Rewriting the "intrinsic properties" of a substance

Many active compounds (e.g., coenzyme Q10, curcumin) pack too tightly in their natural crystalline state—like a dense brick wall that water cannot penetrate, resulting in extremely low aqueous solubility. Cocrystallization is like inserting "wedges" (coformer molecules) into that brick wall, prying apart the gaps and altering the overall packing structure. Water molecules can now infiltrate more easily, dramatically improving solubility and dissolution rate [4]. The active ingredient's chemical structure remains unchanged, but its crystal lattice is entirely rebuilt—this is "molecular architecture," not chemical reaction.

Level 2: Achieving "1+1>2" synergy at the molecular level

Cocrystals can also "weld" two or more synergistic active ingredients together at the molecular level into a single new crystal. This is not a simple physical mixture—they coexist in the same lattice at a fixed molar ratio. Upon ingestion, both components release and absorb simultaneously, acting on targets in concert—achieving synergistic effects unattainable by either component alone or by physical blends [4][5].

What These Technologies Cannot Solve

Interestingly, each technology's weakness stems directly from its core strength.

• Microcapsules: Effectiveness depends on complete core coating—incomplete encapsulation fails protection; improper wall material hinders release. But the more fundamental limitation: it addresses "protection," not "absorption." The ingredient may reach the intestine intact, but whether it crosses the membrane still depends on its own permeation ability—microencapsulation offers no direct intervention [1].

• Liposomes: High delivery efficiency comes from the phospholipid bilayer, which is also their Achilles' heel—ester bonds hydrolyze, unsaturated fatty acid chains oxidize, membrane disruption leads to leakage and rancidity. In scaled production, particle size distribution is often uneven (CV >15%), batch intervals exceed 48 hours, and labor-plus-energy costs account for over 60% of total production—final product costs far exceed those of conventional formulations [3].

• Cocrystals: The more fundamental risk—phase transition. All benefits of cocrystals presuppose that the cocrystal form is maintained. However, during dissolution or in gastrointestinal environments, cocrystals may dissociate, and the active ingredient may recrystallize into its low-solubility native form—instantly nullifying the solubility advantage. Long-term storage with temperature/humidity fluctuations can also trigger crystal transformation [5]. On the R&D side, coformer screening requires stringent molecular matching—not every ingredient can find a suitable partner.